NEWS

2022.05.31

Press Releases

Santen and ActualEyes start registering patients to participate in Phase II clinical trial （Phase IIa / PoC study, PHANTOM study）for Fuchs endothelial corneal dystrophy

2021.11.18

Press Releases

Santen and ActualEyes sign a joint development agreement on Phase II clinical trial (Phase II a / PoC study) for a treatment candidate for Fuchs endothelial corneal dystrophy

2021.05.14

Press Releases

ActualEyes and Arctic Vision announce a licensing agreement to develop and commercialize ActualEyes’ lead product candidate, AE101

2019.10.10

Press Releases

Implemented a third-party allocation of new shares

This website uses cookies for the purpose of operating our services and improving the user experience. For details, please refer to our privacy policy. By clicking on the “Agree” button or continuing to use our website, you will be regarded as having agreed to our use of cookies.